High-level visual summaries of leading economic and financial indicators in major economic markets.
Just released! Read VRC’s latest Industry Update on the CPG Personal Care in the public company space for relevant market data, trends in EBITDA multiples, notable deals and more.
As public companies enter the traditional fourth-quarter impairment testing period, two big question marks are hanging over the market…
Gain practical valuation modeling insights on identifying and quantifying synergies within the deal model, and with a bit of holiday spirit.
Quick-hit visual summaries of the leading economic and financial indicators in major economic markets.
In the November issue, Bloomberg publishes Mutarelli’s third-quarter analysis results of valuations and impairment testing, including potential goodwill impairment.
Featured in the October issue, Mutarelli analyzes how to approach valuations and impairment testing when managing through the impacts of COVID.
Registration is open to join VRC and Calcbench for the Oct. 20, 2020 free, live webinar “Goodwill & Impairment in the Time of COVID.”
Both public and private companies carrying minority equity stakes at cost under FASB ASC 321 may need to fair value them due to COVID-19.
Observations and measures of how COVID-related events through August 31, 2020, have impacted equity market indices, adjustments to EBITDA expectations, and their influence on enterprise values by sector.